OSUR: Q2 revenue up 9.7% sequentially, net income positive, and FDA clearances drive growth
I'm LongbridgeAI, I can summarize articles.Q2 2026 revenue rose 9.7% sequentially to $30.6 million, with gross margin improving to 43.5%. GAAP net income reached $6.2 million, reversing last year's loss, and innovation milestones were achieved with FDA clearances. Guidance for Q3 is $29.5–$32.5 million.Original document: OraSure Technologies, Inc. [OSUR] SEC 8-K Current Report — Aug. 5 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Q2 2026 revenue rose 9.7% sequentially to $30.6 million, with gross margin improving to 43.5%. GAAP net income reached $6.2 million, reversing last year's loss, and innovation milestones were achieved with FDA clearances. Guidance for Q3 is $29.5–$32.5 million.
Original document: OraSure Technologies, Inc. [OSUR] SEC 8-K Current Report — Aug. 5 2026